Minnetonka, MN · Founded 2013 · Privately Held (backing)
Developer of artificial intelligence (AI) diagnostic tools designed to improve the detection and management of cardiovascular disease. Angioinsight is based in Minnetonka, MN and was founded in 2013. It is valued at about $18 million as of Oct 2026, set by institutional fund marks. It has raised $10.5 million.
PMV mark · valuation
$18.0M
Oct 2026
Priced at
—
Total raised
$10.5M
Last round
—
Cap table — not yet on record
Angioinsight's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
